Download PDF

ERRATA
Van Staa A, Jedeloo S, Latour J, Trappenburg M. A Normal Life
With an Unhealthy Body: Self-identity in Adolescents Growing Up
With Chronic Illness. PEDIATRICS 2008;121(suppl 2):S103
An error occurred in the article by AnneLoes Van Staa, titled “A normal life
with an unhealthy Body: Self-identity in Adolescents growing up with
chronic illness” published in January 2008, volume 121, Supplement 2. On
page S103, in affiliations the publisher wrote: “ cAgia Sophia Children’s
Hospital, Athens, Greece.” This should have read: “ cErasmus Medical Centre—Sophia Children’s Hospital, Rotterdam, the Netherlands” On page S103,
under the heading “Methods” on line 6, the publisher wrote “Erasmus
Medical Centre—Agia Sophia Children’s Hospital.” This should have read:
“Erasmus Medical Centre—Sophia Children’s Hospital, Rotterdam, the Netherlands.”
doi:10.1542/peds.2008-1371a
Van Staa A, Jedeloo S, Latour J, van Exel J. Using Q-Methodology
to Explore Preferences For Care of Adolescents With Chronic
Disorders: 4 Profiles. PEDIATRICS 2008;121(suppl 2):S154
An error occurred in an article by AnneLoes Van Staa, titled “Using QMethodology to explore preferences for care of adolescents with chronic
disorders: 4 profiles” published in January 2008, volume 121, Supplement 2.
On page S154, in affiliations the publisher wrote: “bAgia Sophia Children’s
Hospital, Erasmus Medical Center, Rotterdam, The Netherlands.” This
should have read: “cErasmus Medical Center—Sophia Children’s Hospital,
Rotterdam, the Netherlands.” On page S154, in affiliations the publisher
wrote: “cInstitute of Health Policy and Management.” This should have read:
“bInstitute of Health Policy and Management, Erasmus Medical Center,
Rotterdam, the Netherlands.” On page S154, under “Methods” the publisher
wrote: “Erasmus Medical Centre—Agia Sophia Children’s Hospital.” This
should have read: “Erasmus Medical Centre—Sophia Children’s Hospital.”
doi:10.1542/peds.2008-1371b
Abstracts of the 25th International Congress of Pediatrics, August
25–30, 2007, Athens, Greece. PEDIATRICS 2008;121(suppl 2):S138
An error occurred in the January 2008 issue of Pediatrics (Volume 121,
Supplement 2). On page S138, under the section Neonatology, after line 19
the authors should have included the following abstract:
CONTINUOUS-INFUSION VANCOMYCIN THERAPY IN THE NEONATAL POPULATION IMPROVES VANCOMYCIN SERUM CONCENTRATIONS
Submitted by Andrew Kapetanakis
Andrew Kapetanakis, Sarah Bradley, Kate Farrer
Neonatal Unit, St George’s Hospital, London, UK
BACKGROUND: Vancomycin is a valuable antibiotic in neonatal intensive
care although the optimal administration regime has not been established.
Intermittent drug administration regimens do not produce consistently sat-
226
ERRATA
Downloaded from by guest on June 16, 2017
isfactory drug levels. The most important pharmacokinetic parameter is the
24-hour area under the serum concentration time concentration curve (24 h
AUC) in relation to minimal inhibitory concentration (MIC). Continuous
infusion (CI) of Vancomycin would therefore be more appropriate in improving serum drug concentrations and bactericidal activity. To date there is
limited experience of CI-Vancomycin therapy in neonates.
OBJECTIVE: To evaluate the use of a new CI-Vancomycin therapy regimen
in neonates.
DESIGN & METHODS: Prospective data collection from infants receiving a
loading dose of 15 mg/kg followed by CI-Vancomycin. The starting doses
were 15 mg/kg/day - 30 mg/kg/day depending on the initial serum creatinine level. Drug levels were obtained at 24-48 hour intervals and the dose
adjusted accordingly. Target steady state concentration was 15-25 mcg/ml.
RESULTS: (Mean ⫾ Standard deviation): 111 Vancomycin courses were
evaluated between November 2002 and November 2006. Gestational age
was 28.5 (⫾5) weeks and birth weight was 1.24 (⫾0.88) kg. Corrected age
was 34.9 (⫾8) weeks. The dosing schedule was adjusted 2.4 (⫾2) times. The
duration of the treatment was 12.5 (⫾5.8) days. 48-hour steady state vancomycin concentration was 16.25 (⫾8.2) mcg/ml (63% ⬎15 mcg/ml) and
was improved further during the treatment course.
CONCLUSIONS: CI-Vancomycin administration was well tolerated and
resulted in improved drug concentrations in the neonatal population. Drug
levels need to be monitored regularly and the dose needs to be adjusted
accordingly to achieve optimal results.
doi:10.1542/peds.2008-1372
Bangs ME, Hazell P, Danckaerts M, et al. Atomoxetine for the
Treatment of Attention-Deficit/Hyperactivity Disorder and
Oppositional Defiant Disorder. PEDIATRICS 2008;121(2):e314 – e320
An error occurred in the article by Mark Bangs et al, titled “Atomoxetine for
the treatment of attention-deficit/hyperactivity disorder and oppositional
defiant disorder” published in the February 2008 issue of Pediatrics (doi:
10.1542/peds.2006-1880). The authors regret that they failed to include, in
the second line of the acknowledgement, the institutions at which the
research was performed. The text should have read as follows:
“We thank the investigators and their staff comprising the ADHD/ODD
Study Group: Els Van den Ban, Universitair Medisch Centrum Utrecht,
Utrecht, Netherlands; Dirk Deboutte, Algemeen Zkhs Middelheim, Antwerpen, Belgium; Daryl Efron, Royal Childrens Hospital Melbourne, Parkville,
Australia; Herman van Engeland, Universitair Medisch Centrum Utrecht,
Utrecht, Netherlands; Jorg M. Fegert, Universitats-Kinderklinik u. PoliklinikUni Klinikum Ulm, Ulm, Germany; Rutger Jan van der Gaag, Academisch
Centrum voor Kinder-en Jeugdpsychitrie Oos, Nijmegen, Netherlands; Eija
Nikkanen, Hyks Lasten ja Nuorten Sairaal, Helsinki, Finland; Xavier Gastaminza Pe⬘rez, Hospital Vall de Hebron, Barcelona, Spain; Martin Schmidt,
Zentralinstitut fur Seelische Gesundheit, Mannheim, Germany; Cesar
Soutullo, Clinica Universitaria de Navarra, Pamplona, Navarra, Spain; Per
Hove Thomsen, Dorne-og Ungdomspsykiatrisk Hospital, Risskov, Denmark;
Lennart von Wendt, Hyks Lasten ja Nuorten Sairaal, Helsinki, Finland; and
Amaia Hervas Zuniga, Hospital Mutua de Terrassa, Barcelona, Spain.”
doi:10.1542/peds.2008-1497
Downloaded from by guest on June 16, 2017
PEDIATRICS Volume 122, Number 1, July 2008
227
ERRATA
Pediatrics 2008;122;226
DOI: 10.1542/peds.2008-1372
Updated Information &
Services
including high resolution figures, can be found at:
/content/122/1/226.2.full.html
Permissions & Licensing
Information about reproducing this article in parts (figures,
tables) or in its entirety can be found online at:
/site/misc/Permissions.xhtml
Reprints
Information about ordering reprints can be found online:
/site/misc/reprints.xhtml
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
publication, it has been published continuously since 1948. PEDIATRICS is owned, published,
and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk
Grove Village, Illinois, 60007. Copyright © 2008 by the American Academy of Pediatrics. All
rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Downloaded from by guest on June 16, 2017
ERRATA
Pediatrics 2008;122;226
DOI: 10.1542/peds.2008-1372
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
/content/122/1/226.2.full.html
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
publication, it has been published continuously since 1948. PEDIATRICS is owned,
published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point
Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2008 by the American Academy
of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Downloaded from by guest on June 16, 2017